Navigation Links
Preclinical Data on Lead MEK Inhibitor, RDEA119, to be Presented at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Date:10/8/2007

- RDEA119: A Potent and Selective MEK inhibitor with Favorable In Vitro and

In Vivo Anti-Tumor Properties -

CARLSBAD, Calif., Oct. 8 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Pink Sheets: ARDC), a company focused on the discovery and development of small-molecule therapeutics for the treatment of viral diseases, cancer and inflammatory diseases, today announced that preclinical data on its lead MEK inhibitor, RDEA119, will be presented at the American Association of Cancer Research (AACR), National Cancer Institute (NCI) and European Organization for Research and Treatment of Cancer (EORTC) International Conference on Molecular Targets and Cancer Therapeutics in San Francisco, October 22-26, 2007. The abstract entitled "RDEA119: A Potent and Highly Selective MEK Inhibitor for the Treatment of Cancer," will be presented on October 24, 2007 at 12:30 p.m. Pacific Standard Time.

Event: AACR-NCI-EORTC International Conference on Molecular Targets

and Cancer Therapeutics

Title: RDEA119: A Potent and Highly Selective MEK Inhibitor for the

Treatment of Cancer

Date: Wednesday, October 24, 2007

Time: 12:30 - 2:30 p.m. and 5:30 - 7:30 p.m. Pacific Standard Time

Location: Poster Session B -- Exhibit Hall, First Floor, Moscone

Convention Center West

About RDEA119 and Ardea's MEK Inhibitor Program

Ardea Biosciences has a broad-based R&D program focused on the design and development of small-molecule inhibitors of mitogen-activated ERK kinase, or MEK, for the treatment of cancer and inflammatory diseases. Since defects in the RAS/RAF/MEK/ERK signaling pathway are closely associated with the development of human tumors, such as melanoma, colon, lung and thyroid cancers, inhibiting MEK signaling has promise in the treatment of many types of cancer. MEK inhibitors may also play an important role in the potential treatment of inflam
'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
3. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
4. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
5. ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical Model
6. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
7. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
8. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
9. Genaera to Present Preclinical Data on Trodusquemine for the Treatment of Obesity at the American Diabetes Association 67th Scientific Sessions
10. Metabasis Therapeutics Presents Results of Preclinical Studies for MB07811, Its Novel Product Candidate for the Treatment of Hyperlipidemia, at the Endocrine Societys Annual Meeting
11. Elixir Pharmaceuticals Presents Additional Preclinical Data Demonstrating the Potential of Ghrelin Antagonism to Regulate Metabolism, Body Weight and Glycemic Control

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... Arcadia Resources, Inc. ...ve consumer health care services under the Arcadia...mith to its Board of Directors. Goldsmith will re... the Board. ,, (Photo: http://www.newscom....ith is the Daniel Paul Professor of Government and...
(Date:11/9/2009)...v. 9 /PRNewswire-Asia/ -- Chindex International, I...ndent American provider of Western,healthcare prod...a, today,announced results for the second quarter ...er 30, 2009. , , Financial Highlights:, -- ...38.1 million, flat on, a year over year basi...
(Date:11/9/2009)...Nov. 9 Clarient, Inc. (N...resource for pathologists, oncologists and the pha...cheduled to make presentations at two upcoming inv...t presentation will be made at the Lazard Capital ... pm EST on Tuesday, November 17. The conference wi...
Breaking Medicine Technology:Arcadia Resources Names Stephen Goldsmith to Board of Directors 2Arcadia Resources Names Stephen Goldsmith to Board of Directors 3Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 2Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 3Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 4Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 5Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 6Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 7Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 8Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 9Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 10Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 11Clarient to Present at Upcoming Healthcare Investor Conferences in New York City 2RAPS Honors Dexter Shorer and Novales Li for Outstanding Contributions to Healthcare Product Regulatory Profession 57049 1RAPS Honors Dexter Shorer and Novales Li for Outstanding Contributions to Healthcare Product Regulatory Profession 57049 2RAPS Honors Dexter Shorer and Novales Li for Outstanding Contributions to Healthcare Product Regulatory Profession 57049 3Health Reform and A Health Insurance Broker 57044 1Health Reform and A Health Insurance Broker 57044 2Lilly Unveils Blueprint for Speeding Innovative Medicines to Patients 57041 1Lilly Unveils Blueprint for Speeding Innovative Medicines to Patients 57041 2Lilly Unveils Blueprint for Speeding Innovative Medicines to Patients 57041 3Lilly Unveils Blueprint for Speeding Innovative Medicines to Patients 57041 4Lilly Unveils Blueprint for Speeding Innovative Medicines to Patients 57041 5
...eGen, Inc. today announced that,the Company has st...TG101348, an oral, potent, and highly selective in...e diseases., (Logo: http://www.newscom.com/cgi-b...on of JAK2 is implicated in the pathogenesis of ce...ythemia vera (PV), essential,thrombocytopenia (ET)...
...NTRX Pharmaceuticals,Inc. (Amex: ANX ), announced...01, the Company,s broad spectrum antiviral product...the Keystone Symposia HIV Pathogenesis,Conference,..., Alberta. The,HIV Pathogenesis Conference is part...ich is supported by the Bill & Melinda Gates Found...
Other Medicine Technology:TargeGen Announces Initiation of Clinical Trial of JAK2 Inhibitor TG101348 in Myeloproliferative Disease Patients 2ADVENTRX to Present ANX-201 Preclinical Data at Keystone Symposia HIV Pathogenesis Conference 2ADVENTRX to Present ANX-201 Preclinical Data at Keystone Symposia HIV Pathogenesis Conference 3
(Date:11/9/2009)...ustry leader readies its award-winning solutions t...e IT risk on Windows 7 and Windows Server 2008 R2;...diness. , Scottsdale, AZ ...   As businesses ready their IT environme...8 Server R2, Lumension , a global leader in endpo...
(Date:11/9/2009)...’s Today Show featured a return of the Berns...Friday Nov. 6th 2009, The segment followed up wit... appearance on the Today Show on May 28th 2009 in ...g their treatments by Dr. Jill Waibel of Miami, FL... (PRWEB) November 9, 2009 -...
(Date:11/9/2009)...s device is ideal for endurance athletes to streng...opCompex.com , San Diego,...nd of DJO Incorporated, a global provider of muscu...e the launch of the latest electrical muscle stim...Sport Elite was designed to complement the rigorou...
(Date:11/9/2009)...couver Career College launches month-long clothing...rey, BC (Vocus) November 9, 2009 -- The students a... digging through their closets to find clothing to...he same in order to help women and children in nee...a community here on campus amongst our students, s...
(Date:11/9/2009)...Newswire-USNewswire/ -- In the wake of the Fort Ho...action to all mental health professionals in Texas...an Hour(TM) is a national nonprofit organization p...ervices to active duty service members, members of...ns of Iraq and Afghanistan who have separated or r...
Breaking Medicine News(10 mins):Health News:Lumension Provides Enhanced Endpoint Protection and Support for The Latest Windows Platforms 2Health News:Lumension Provides Enhanced Endpoint Protection and Support for The Latest Windows Platforms 3Health News:Lumension Provides Enhanced Endpoint Protection and Support for The Latest Windows Platforms 4Health News:Lumenis Ultrapulse TotalFX Featured for the Treatment of Burn Scars on the Today Show 2Health News:Lumenis Ultrapulse TotalFX Featured for the Treatment of Burn Scars on the Today Show 3Health News:Lumenis Ultrapulse TotalFX Featured for the Treatment of Burn Scars on the Today Show 4Health News:COMPEX Intoduces New Sport Elite Electrical Muscle Stimulation Unit 2Health News:COMPEX Intoduces New Sport Elite Electrical Muscle Stimulation Unit 3Health News:Surrey College Students Collect Clothing for Women and Children 2Health News:Give an Hour(TM) Partners with American Red Cross and Calls All Mental Health Professionals in Texas to Volunteer Their Services 2
...d man’, ‘old fogies’ and other such, this is not t.../. Surprisingly, it’s older people who are more op...t people become more positive as they get older, a... to look at several images for a few seconds. Duri...
...newly diagnosed breast cancer patients is responsi...ery// in the United States, according to a new stu...NCER, a peer-reviewed journal of the American Canc...me of treatment planning. Despite the fact t...
... one by parliamentarians of Britain and India, vis... "Even though TB is easily curable, over 1.5 m... We think parliamentarians of Britain and India mu...a five-member team to India for a firsthand look a...
...wing (MI), can be used to reduce alcohol abuse by ...al drinking age//, according to Psychologists. ...ide students in a process of resolving a situation...gnizing the discrepancies between their current be...
...ll Cornell Medical College could prove a potent we...e compound, called SS31, is able to cross the bloo...lecule recently linked to stroke-related tissue da... affected," says the study's lead author Dr. Sungh...
...ned people that at least 90 people have been attac...// in the island republic. They said the species l...ssels among others. The warning came in the ...ingapore 12 hours after he was infected with Vibri...
Other Medicine News:Health News:Breast Cancer Patients Unaware of Reconstructive Surgery 2Health News:British MP Stress the Need to Fight Against TB Jointly With India 2Health News:Motivational Interviewing Could Reduce Excessive Drinking by Students 2Health News:Antioxidant Molecule Could Help Minimize Stroke-Linked Brain Damage 2
DELFIA Platewash
8 Channel ImmunoWasher
...signed to meet the working and budgetary laborator...user to run set assays at the touch of a button. T...to wash 8 or 12 wells at a time. Reliable, compact...rfill protection, quiet operation, and minimal mai...
SkanWasher 300 (110V)
Medicine Products: